Abstract:Background: Emerging research indicates that long non-coding RNAs are involved in physiological and pathological processes, especially cancer. AFAP1-AS1 is a 6810-nt lncRNA located on chromosome 4p16.1 that was first reported to be up-regulated in esophageal adenocarcinoma tissues. However, its biological activities and underlying mechanisms in non-small cell lung cancer (NSCLC) remain to be fully elucidated. Methods: qRT-PCR was performed to determine AFAP1-AS1 expression in 96 paired NSCLC tissues and cell lines. The effect of AFAP1-AS1 on cell phenotype was assessed by CCK-8, colony formation, flow cytometry and EdU experiments, and a xenograft mouse model was used for in vivo studies. Transwell assays were arranged to detect cell migration. RNA transcriptome sequencing, RIP, ChIP and rescue assays were used to highlights the potential molecular mechanism. Findings: AFAP1-AS1 was generally up-regulated in NSCLC, and higher AFAP1-AS1 expression was significantly correlated with larger tumor size (p=0.008), lymph node metastasis (p=0.025), higher TNM stage (p=0.024), and worse overall survival in NSCLC patients. In vitro experiments revealed that AFAP1-AS1 down-regulation inhibited cell proliferation, migration and induced cell apoptosis; AFAP1-AS1 knockdown also hindered tumorigenesis in vivo. Moreover, mechanistic investigations revealed that AFAP1-AS1 repressed HBP1 (HMG box-containing protein 1) expression via recruiting demethylase LSD1 to the HBP1 promoter regions. Furthermore, rescue assays showed that the oncogenic function of AFAP1-AS1 is partially dependent on the epigenetic silencing of the tumor suppressor HBP1. Interpretation: Our results indicate that AFAP1-AS1 is carcinogenic and that the AFAP1-AS1 / LSD1 / HBP1 axis may constitute a potential factor or a new therapeutic direction for NSCLC. Funding: This work was supported by grants from the National Natural Science Foundation of China (No. 81672307, 81871871), the Medical Innovation Team Foundation of the Jiangsu Provincial Enhancement Health Project (No. CXTDA2017021), the “333 high class Talented Man Project” (No. BRA2016509), the Nanjing Science and Technology Development Project (No. 2017sc512046), and the Jiangsu Graduate Scientific Research Innovation Program (No. KYCX18_1494). Declaration of Interest: The authors have no conflicts of interest to declare. Ethical Approval: We obtained written informed consent from all patients before surgery and the study was approved by the Research Ethics Committee of The Second Affiliated Hospital of Nanjing Medical University.

Long Noncoding RNA LHFPL3-AS2 Suppresses Metastasis of Non-Small Cell Lung Cancer by Interacting with SFPQ to Regulate TXNIP Expression.

Abstract 991: Long Non-Coding RNA LINC01133 Inhibits Epithelial-Mesenchymal Transition and Metastasis in Colorectal Cancer by Interacting with SRSF6

Loss of Long Noncoding RNA FOXF1-AS1 Regulates Epithelial-Mesenchymal Transition, Stemness and Metastasis of Non-Small Cell Lung Cancer Cells.

Long non-coding RNA OR3A4 is associated with poor prognosis of human non-small cell lung cancer and regulates cell proliferation via up-regulating SOX4.

Long Non-Coding RNA RFPL3S is a Novel Prognostic Biomarker in Lung Cancer

Long Intergenic Noncoding Rna 00673 Promotes Non-Small-Cell Lung Cancer Metastasis by Binding with Ezh2 and Causing Epigenetic Silencing of Hoxa5

Long Non-Coding Rna 00312 Regulated by Hoxa5 Inhibits Tumour Proliferation and Promotes Apoptosis in Non-Small Cell Lung Cancer

LncRNA AC100826.1 regulated PLCB1 to promote progression in non‐small cell lung cancer

Upregulation of Long Intergenic Noncoding RNA 00673 Promotes Tumor Proliferation Via LSD1 Interaction and Repression of NCALD in Non-Small-cell Lung Cancer.

Long Non-Coding RNA AFAP1-AS1 Promotes Non-Small Cell Lung Cancer Cell Proliferation and Migration Via Binding with LSD1 and Repressing HBP1 Expression

LncRNA SNHG3 Promotes Proliferation and Metastasis of Non-Small-Cell Lung Cancer Cells Through miR-515-5p/SUMO2 Axis

LINC01503/miR-342-3p facilitates malignancy in non-small-cell lung cancer cells via regulating LASP1

Long Noncoding RNA SFTA1P Promoted Apoptosis and Increased Cisplatin Chemosensitivity Via Regulating the Hnrnp-U-gadd45a Axis in Lung Squamous Cell Carcinoma.

Effects and Mechanisms of Lncrna RP11-366L20.3 on Non-small Cell Lung Cancer Metastasis

LncRNA SNHG1 influences cell proliferation, migration, invasion, and apoptosis of non‐small cell lung cancer cells via the miR‐361‐3p/FRAT1 axis

LINC01348 suppresses hepatocellular carcinoma metastasis through inhibition of SF3B3-mediated EZH2 pre-mRNA splicing

Long Non-Coding RNA LINC00339 Facilitates the Tumorigenesis of Non-Small Cell Lung Cancer by Sponging Mir-145 Through Targeting FOXM1.

LncRNA MAGI2-AS3 acts as a tumor suppressor that attenuates non-small cell lung cancer progression by targeting the miR-629-5p/TXNIP axis

Long non-coding RNA SNHG15 accelerates the progression of non-small cell lung cancer by absorbing miR-211-3p

ZFPM2-AS1 promotes the proliferation, migration, and invasion of human non-small cell lung cancer cells involving the JAK-STAT and AKT pathways

Upregulated long non-coding RNA AGAP2-AS1 represses LATS2 and KLF2 expression through interacting with EZH2 and LSD1 in non-small-cell lung cancer cells